Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Supply Disruption — Akorn, Inc. (Moderate Risk — T
Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn Supply Disruption — Akorn, Inc. (Moderate Risk — T is one of 9,000 drug supply records in the DrugSupply dataset. Key details — Drug name: Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn; Manufacturer: Akorn,
| Drug name | Rifampin Capsules, USP, 150 mg, 30-count bottle, Rx only, Distributed by: Akorn |
|---|---|
| Manufacturer | Akorn, Inc. |
| Recall/Disruption reason | Failed impurities/degradation specifications: Finished product exceeds the 5 ppm interim limit for 1-Methyl-4-Nitrosopop |
| Risk classification | Moderate Risk — Temporary Health Consequence |
| Status | Ongoing |
| Record type | Enforcement/Recall |
| Recall number | D-1547-2022 |
| Initiation date | 20220921 |
| Quantity affected | 18,145 bottles |
| Dosage form | Drugs |
🔍 Search all drug supply records →
$1199/mo
Try DrugSupply →